MDT

— Fundamental Stock Analysis and Report Card

Healthcare : Medical - Devices

Located in Galway, GA, IE. Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Growth

Revenue, earnings and profitability.

Strong revenue growth and earnings can attract investors, driving the stock price up. Profitability indicates the company's efficiency and sustainability, which impacts investor confidence. Poor performance in these areas can lead to a decrease in stock price.

Revenue History

Earnings History

Margins

Gross Margin TTM
65.02%
EBITDA Margin TTM
26.72%
Net Margin TTM
13.20%
Earnings Per Share TTM
3.74
Statements

Income & Cash Flow analysis.

An income statement shows what a company earned and spent over a period — revenue at the top, costs and expenses in between, and net income at the bottom. A cash flow statement tracks the actual cash moving in and out, across operations, investing, and financing. Read together, they show whether reported earnings are backed by real cash.

Medtronic plc
Select Period:
Q4 2026
Total ($)
Q4 2026
Margin (%)
Revenue
9.8b
+880.0m
+9.9%
Gross Income
7.4b
+1.7b
+28.7%
76%
+11.1pp
+17.2%
EBITDA
2.6b
+362.0m
+15.9%
27%
+1.4pp
+5.5%
Operating Income
1.6b
+128.0m
+8.9%
16%
-0.1pp
-0.9%
Net Income
1.2b
+186.0m
+17.6%
13%
+0.8pp
+7.0%
Earnings Per Share
0.98
+0.2
+19.5%
Operating Cash Flow
2.6b
+45.0m
+1.8%
26%
-2.1pp
-7.4%
Free Cash Flow
2.1b
+16.0m
+0.8%
21%
-1.9pp
-8.3%
Research & Development
671.0m
-13.0m
-1.9%
7%
-0.8pp
-10.7%